Search Results - "Feldt-Rasmussen U"

Long-term Pathologic Changes of α 1 -Acid Glycoprotein (orosomucoid) Glycoforms in Autoimmune Thyroid Disease.

Authors: Zimmermann-Belsing, T. Feldt-Rasmussen, U. From, G. et al.

Source: Autoimmunity. Nov2002, Vol. 35 Issue 7, p441-447. 7p.

Fabry disease in children: agalsidase-beta enzyme replacement therapy.

Authors: Borgwardt, L Feldt‐Rasmussen, U Rasmussen, AK et al.

Source: Clinical Genetics. May2013, Vol. 83 Issue 5, p432-438. 7p. 2 Charts, 3 Graphs.

This result is not displayed to guests.
Login for full access.

Decrease in scale invariance of activity fluctuations with aging and in patients with suprasellar tumors.

Authors: Joustra, S. D. Gu, C. Rohling, J. H. T. et al.

Source: Chronobiology International: The Journal of Biological & Medical Rhythm Research. Mar2018, Vol. 35 Issue 3, p368-377.

Can growth hormone therapy cause diabetes? KIMS Strategic Committee.

Authors: Monson, J P Bengtsson, B A Abs, R et al.

Source: Lancet. 5/13/2000, Vol. 355 Issue 9216, p1728-1729. 2p.

Subjects: Insulin resistance, Type 2 diabetes, Somatomedin, Human growth hormone, Treatment effectiveness

Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency.

Authors: Hernberg-Stahl, E. Luger, A. Abs, R. et al.

Source: Journal of Clinical Endocrinology & Metabolism. 2001: Vol. 86 Issue 11. p. 5277-5281-5281.

This result is not displayed to guests.
Login for full access.

Lack of thyroglobulin synthesis as an indicator of early random dedifferentiation of the Fischer rat thyroid cell line FRTL-5.

Authors: Zimmermann-Belsing, T Krogh Rasmussen, Å Feldt-Rasmussen, U

Source: Scandinavian Journal of Clinical & Laboratory Investigation. 12/30/98, Vol. 58 Issue 7, p529-536. 8p. 4 Graphs.

Should Primary Hyperparathyroidism at Age Below 40 Years Always Lead to Search for MEN-1, Despite Presence of Other Plausible Explanations?

Authors: Feldt-Rasmussen, U. Rasmussen, Å. K. Friis-Hansen, L.

Source: Neuroendocrinology. Jul2012 Supplement, Vol. 96, p30-30. 1/3p.

P20—Agalsidase Beta Treatment is Associated With Improvement in Quality of Life in Patients With Fabry Disease: Findings From the Fabry Registry.

Authors: Feldt-Rasmussen, U. Watt, T. Burlina, A.P. et al.

Source: Clinical Therapeutics. Apr2012 Supplement, Vol. 34, pe26-e26. 1p.

URL: 74553606

The influence of alpha1-acid glycoprotein (orosomucoid) and its glycoforms on the function of human thyrocytes and CHO cells transfected with the human TSH receptor

Authors: Zimmermann-Belsing, T. Rasmussen, Å.K. Feldt-Rasmussen, U. et al.

Source: Molecular & Cellular Endocrinology. Feb2002, Vol. 188 Issue 1/2, p241. 11p.

THE ROMANIAN VERSION OF THE THYROID-RELATED PATIENT-REPORTED OUTCOMES THYPRO AND THYPRO-39. TRANSLATION AND ASSESSMENT OF RELIABILITY AND CROSSCULTURAL VALIDITY.

Authors: Zahan, A. E. Watt, T. Pascanu, I. et al.

Source: Acta Endocrinologica (1841-0987). Apr-Jun2018, Vol. 14 Issue 2, p192-200. 9p.

Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensus.

Authors: Moreno-Martinez, D. Aguiar, P. Auray-Blais, C. et al.

Source: Molecular Genetics & Metabolism. Apr2021, Vol. 132 Issue 4, p234-243. 10p.

Expérience des patients Fabry concernant la perfusion mensuelle de PegunigaLsidasE Alfa - étude PEOPLE.

Authors: Eyskens, F. Ankit, M. Pisani, A. et al.

Source: Revue de Médecine Interne. 2024 Supplement 1, Vol. 45, pA142-A143. 2p.

Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat.

Authors: Germain, D. P. Hughes, D. A. Nicholls, K. et al.

Source: New England Journal of Medicine. 8/11/2016, Vol. 375 Issue 6, p545-555. 11p.

P1.10 Autonomic control of heart rate and blood pressure in Anderson–Fabry's disease

Authors: Mehlsen, J. Ballegaard, M. Feldt-Rasmussen, U. et al.

Source: Autonomic Neuroscience: Basic & Clinical. Aug2009, Vol. 149 Issue 1/2, p63-63. 1p.

Diversity of neuropathy in a familywith Fabry disease

Authors: Møller, A.T. Bach, F.W. Feldt-Rasmussen, U. et al.

Source: Clinical Therapeutics. Mar2007 Supplement A, Vol. 29 Issue SUPP, pS24-S25. 0p.

Hair removal in hirsute women with normal testosterone levels: a randomized controlled trial of long-pulsed diode laser vs. intense pulsed light C.S. Haak et al. Laser vs. IPL in hirsute women with normal testosterone.

Authors: Haak, C. S. Nymann, P. Pedersen, A.T. et al.

Source: British Journal of Dermatology. Nov2010, Vol. 163 Issue 5, p1007-1013. 7p. 1 Diagram.

Hypothyroidism is associated with signs of endothelial dysfunction despite 1-year replacement therapy with levothyroxine.

Authors: Clausen, P. Mersebach, H. Nielsen, B. et al.

Source: Clinical Endocrinology. Jun2009, Vol. 70 Issue 6, p932-937. 6p. 2 Charts.

Immunohistochemical staining for thyroid peroxidase (TPO) of needle core biopsies in the diagnosis of scintigraphically cold thyroid nodules.

Authors: Yousaf, U. Christensen, L. H. Rasmussen, Å. K. et al.

Source: Clinical Endocrinology. Jun2008, Vol. 68 Issue 6, p996-1001. 6p. 3 Color Photographs, 4 Charts.